FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Guido Finazzi

Research Profile

Disorders

Anatomy

Thrombosis

Concepts & Ideas

Chemicals & Drugs

Physiology

Mutation

Co-author Network

Publications

TOP 3
Paola Guglielmelli; Maria Letizia Lupo; Elisa Malevolti; Roberto Marchioli; Arianna Masciulli; Ubaldo Occhini; Alessandro Pancrazzi; Simona Paratore; Lisa Pieri; Alessandro Rambaldi; Maria Chiara Susini; Lorenzo Tozzi; Emilio Usala; Alessandro M Vannucchi; Elisabetta Antonioli; Tiziano Barbui; Giovanni Barosi; Niccolò Bartalucci; Flavia Biamonte; Alberto Bosi; Silvia Caglio; Guido Finazzi; Elisabetta Gattoni; Alberto Grossi
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Tiziano Barbui; Giovanni Barosi; Gunnar Birgegård; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben A Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.
Roberto Marchioli; Arianna Masciulli; Maria Rosaria Mennitto; Giorgina Specchia; Guido Finazzi; Tiziano Barbui
The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Guido Finazzi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Paola Guglielmelli; Maria Letizia Lupo; Elisa Malevolti; Roberto Marchioli; Arianna Masciulli; Ubaldo Occhini; Alessandro Pancrazzi; Simona Paratore; Lisa Pieri; Alessandro Rambaldi; Maria Chiara Susini; Lorenzo Tozzi; Emilio Usala; Alessandro M Vannucchi; Elisabetta Antonioli; Tiziano Barbui; Giovanni Barosi; Niccolò Bartalucci; Flavia Biamonte; Alberto Bosi; Silvia Caglio; Guido Finazzi; Elisabetta Gattoni; Alberto Grossi
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Blood 2011;118(8):2069-76.
2011: Tiziano Barbui; Giovanni Barosi; Gunnar Birgegård; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben A Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):761-70.
2011: Roberto Marchioli; Arianna Masciulli; Maria Rosaria Mennitto; Giorgina Specchia; Guido Finazzi; Tiziano Barbui
The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.
Thrombosis 2011;2011():794240.
2010: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Giancarla Gerli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Francesco Rodeghiero; Enrico Pogliani; Guido Finazzi; Luigi Gugliotta; Giuseppe Leone; Tiziano Barbui
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
American journal of hematology 2010;85(2):97-100.
2010: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Nicola Vianelli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Emma Cacciola; Francesco Rodeghiero; Enrico M Pogliani; Guido Finazzi; Luigi Gugliotta; Giuseppe Leone; Tiziano Barbui
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
Annals of hematology 2010;89(2):141-6.
2010: Tiziano Barbui; Alessandra Carobbio; Francisco Cervantes; Alessandro M Vannucchi; Paola Guglielmelli; Elisabetta Antonioli; Alberto Alvarez-Larrán; Alessandro Rambaldi; Guido Finazzi; Giovanni Barosi
Thrombosis in primary myelofibrosis: incidence and risk factors.
Blood 2010;115(4):778-82.
2009: Alessandra Carobbio; Guido Finazzi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro M Vannucchi; Chiara M Dellacasa; Silvia Salmoiraghi; Federica Delaini; Alessandro Rambaldi; Tiziano Barbui
JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera.
Experimental hematology 2009;37(9):1016-21.
2009: Giovanni Barosi; Gunnar Birgegård; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Jean-Jacques Kiladjian; Eva Lengfelder; Mary Frances McMullin; Francesco Passamonti; John T Reilly; Alessandro M Vannucchi; Tiziano Barbui
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.
Blood 2009;113(20):4829-33.
2008: Alessandra Carobbio; Elisabetta Antonioli; Paola Guglielmelli; Alessandro M Vannucchi; Federica Delaini; Vittoria Guerini; Guido Finazzi; Alessandro Rambaldi; Tiziano Barbui
Leukocytosis and risk stratification assessment in essential thrombocythemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2732-6.
2008: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Giancarla Gerli; Nicola Vianelli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Francesco Rodeghiero; Enrico Pogliani; Guido Finazzi; Luigi Gugliotta; Roberto Marchioli; Giuseppe Leone; Tiziano Barbui
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
Haematologica 2008;93(3):372-80.
2008: Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.
Blood 2008;111(2):666-71.
2007: Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegård; Ruben A Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.
Blood 2007;110(4):1092-7.
2007: Monica Galli; Giovanna Borrelli; Eva Marie Jacobsen; Rosa Maria Marfisi; Guido Finazzi; Roberto Marchioli; Finn Wisloff; Stefana Marziali; Olivier Morboeuf; Tiziano Barbui
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
Blood 2007;110(4):1178-83.
2007: Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Rambaldi; Giovanni Barosi; Roberto Marchioli; Rosa Maria Marfisi; Guido Finazzi; Vittoria Guerini; Fabrizio Fabris; Maria Luigia Randi; Valerio De Stefano; Sabrina Caberlon; Agostino Tafuri; Marco Ruggeri; Giorgina Specchia; Vincenzo Liso; Edoardo Rossi; Enrico Pogliani; Luigi Gugliotta; Alberto Bosi; Tiziano Barbui
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.
Blood 2007;110(3):840-6.
2007: Alessandra Carobbio; Guido Finazzi; Vittoria Guerini; Orietta Spinelli; Federica Delaini; Roberto Marchioli; Giovanna Borrelli; Alessandro Rambaldi; Tiziano Barbui
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status.
Blood 2007;109(6):2310-3.
2007: Raffaele Landolfi; Leonardo Di Gennaro; Tiziano Barbui; Valerio De Stefano; Guido Finazzi; Rosa Maria Marfisi; Gianni Tognoni; Roberto Marchioli
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
Blood 2007;109(6):2446-52.
2007: Giovanni Barosi; C Besses; Gunnar Birgegård; Jean Briere; Francisco Cervantes; Guido Finazzi; Heinz Gisslinger; Martin Griesshammer; Luigi Gugliotta; C Harrison; Hans Carl Hasselbalch; Eva Lengfelder; John T Reilly; JJ Michiels; Tiziano Barbui
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.
Leukemia 2007;21(2):277-80.
2007: Guido Finazzi; Alessandro Rambaldi; Vittoria Guerini; Alessandra Carobbo; Tiziano Barbui
Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status.
Haematologica 2007;92(1):135-6.
2007: Marcello Di Nisio; Tiziano Barbui; Leonardo Di Gennaro; Giovanna Borrelli; Guido Finazzi; Raffaele Landolfi; Giuseppe Leone; Rosa Maria Marfisi; Ettore Porreca; Marco Ruggeri; Anne W S Rutjes; Gianni Tognoni; Alessandro M Vannucchi; Roberto Marchioli
The haematocrit and platelet target in polycythemia vera.
British journal of haematology 2007;136(2):249-59.
2005: Guido Finazzi; Roberto Marchioli; V Brancaccio; P Schinco; Finn Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; Tiziano Barbui
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Journal of thrombosis and haemostasis : JTH 2005;3(5):848-53.
2005: Guido Finazzi; Vanesa Caruso; Roberto Marchioli; Giovanni Capnist; Teodoro Chisesi; Carlo Finelli; Luigi Gugliotta; Raffaele Landolfi; Jack Kutti; Heinz Gisslinger; Raphael Marilus; Carlo Patrono; Enrico Pogliani; Maria Luigia Randi; Ana Villegas; Gianni Tognoni; Tiziano Barbui
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.
Blood 2005;105(7):2664-70.
2000: Stefano Sacchi; G Vinci; Luigi Gugliotta; Serena Rupoli; L Gargantini; V Martinelli; S Baravelli; Mario Lazzarino; Guido Finazzi
Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
Haematologica 2000;85(5):492-5.
2000: Monica Galli; Guido Finazzi; F Duca; F Norbis; M Moia
The G1691 --> A mutation of factor V, but not the G20210 --> A mutation of factor II or the C677 --> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants.
British journal of haematology 2000;108(4):865-70.
2000: JJ Michiels; Tiziano Barbui; Guido Finazzi; S M Fuchtman; Jack Kutti; J D Rain; Richard T Silver; A Tefferi; J Thiele
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Leukemia & lymphoma 2000;36(3-4):239-53.
1999: Monica Galli; Guido Finazzi; F Norbis; Stefana Marziali; Roberto Marchioli; Tiziano Barbui
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Thrombosis and haemostasis 1999;81(5):695-700.
1999: Tiziano Barbui; Guido Finazzi
Management of essential thrombocythemia.
Critical reviews in oncology/hematology 1999;29(3):257-66.
1999: JJ Michiels; Jack Kutti; P Stark; M Bazzan; Luigi Gugliotta; Roberto Marchioli; Martin Griesshammer; Perry van Genderen; Josette Brière; Jean-Jacques Kiladjian; Tiziano Barbui; Guido Finazzi; N I Berlin; T C Pearson; A C Green; S M Fruchtmann; Richard T Silver; E Hansmann; A Wehmeier; Eva Lengfelder; Raffaele Landolfi; Hans Michael Kvasnicka; Hans Carl Hasselbalch; Francisco Cervantes; J Thiele
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
The Netherlands journal of medicine 1999;54(2):46-62.
1999: Tiziano Barbui; Guido Finazzi
Clinical parameters for determining when and when not to treat essential thrombocythemia.
Seminars in hematology 1999;36(1 Suppl 2):14-8.
1998: Monica Galli; F Duca; L Ruggeri; Guido Finazzi; B Negri; M Moia
Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.
Thrombosis and haemostasis 1998;80(2):246-9.
1997: Paolo Rebulla; Guido Finazzi; F Marangoni; Giuseppe Avvisati; Luigi Gugliotta; G Tognoni; Tiziano Barbui; F Mandelli; Girolamo Sirchia
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
The New England journal of medicine 1997;337(26):1870-5.
1997: Tiziano Barbui; Guido Finazzi; Monica Galli
[Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1997;12(2):76-83.
1997: Guido Finazzi
The Italian Registry of Antiphospholipid Antibodies.
Haematologica 1997;82(1):101-5.
1996: Tiziano Barbui; Guido Finazzi; A Grassi; R Marchioli
Thrombosis in cancer patients treated with hematopoietic growth factors--a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH.
Thrombosis and haemostasis 1996;75(2):368-71.
1994: Guido Finazzi; Tiziano Barbui
Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
Thrombosis and haemostasis 1994;71(1):15-8.
1990: Guido Finazzi; Tiziano Barbui
[Congenital deficiency of antithrombin III].
Haematologica 1990;75 Suppl 2():6-13.